Kolexia
Coussirou Julie Pharmacien
Coussirou Julie
Pharmacien
Institut Sainte Catherine
Avignon, France
32 Activités
189 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carences en fer Infections à VIH Anémie par carence en fer Vaccins Vaccins contre le SIDA Produits du gène tat du virus de l'immunodéficience humaine Ferritines ADN viral Antirétroviraux

Collaborateurs

Voir plus
De Crozals Francoise
De Crozals Francoise
Institut Sainte Catherine, Avignon, France
Billemont Bertrand
Billemont Bertrand
Institut Sainte Catherine, Avignon, France
Laize-Chanet Brigitte
Laize-Chanet Brigitte
Institut Sainte Catherine, Avignon, France
Stancu Alma
Stancu Alma
Institut Sainte Catherine, Avignon, France

Industries

Voir plus
MSD
5 collaboration(s)
Dernière en 2023
Lilly
4 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2023
Vifor
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Needs assessment for the establishment of an Oral Therapy Unit.
Bulletin du cancer   18 novembre 2022
Identification of factors associated with aggressive end-of-life antitumour treatment: retrospective study of 1282 patients with cancer.
BMJ supportive & palliative care   05 novembre 2020
Impact of ferric carboxymaltose on the evolution of hemoglobin and ECOG performance status in iron-deficient patients with solid tumors: a 3-month follow-up retrospective study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   24 mai 2018
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Retrovirology   09 mai 2016
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
Abstracts of the 2016 International Symposium on HIV and Emerging Infectious Diseases (ISHEID), 25–27 May 2016, Marseille, France   01 mai 2016
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Retrovirology   01 avril 2016
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}